D
Dhruv Mahtta
Researcher at Baylor College of Medicine
Publications - 88
Citations - 792
Dhruv Mahtta is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 73 publications receiving 373 citations. Previous affiliations of Dhruv Mahtta include Veterans Health Administration & Michael E. DeBakey Veterans Affairs Medical Center in Houston.
Papers
More filters
Journal ArticleDOI
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.
TL;DR: The role of ischemic heart disease in the pathogenesis of HF with reduced EF andHFpEF is reviewed, and emerging evidence indicates that impaired myocardial perfusion and inflammation secondary to multiple comorbidities are key mechanisms in HFpEF.
Journal ArticleDOI
Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based Analysis.
Ahmed N. Mahmoud,Siva Sagar Taduru,Amgad Mentias,Dhruv Mahtta,Amr F. Barakat,Marwan Saad,Akram Y. Elgendy,Mohammad K. Mojadidi,Mohamed Omer,Ahmed Abuzaid,Nayan Agarwal,Islam Y. Elgendy,R. David Anderson,Jacqueline Saw +13 more
TL;DR: Women presenting with AMI and SCAD appear to be at higher risk of in-hospital mortality, with evidence of worse outcomes when PCI was performed for SCAD in the setting of non with ST-segment elevation myocardial infarction.
Journal ArticleDOI
Correlation of Altmetric Attention Score With Article Citations in Cardiovascular Research.
Amr F. Barakat,Nayef Nimri,Mohamed Shokr,Dhruv Mahtta,Hend Mansoor,Mohammad K. Mojadidi,Ahmed N. Mahmoud,Mourad H. Senussi,Ahmad Masri,Islam Y. Elgendy +9 more
TL;DR: Social media outlets, particularly Twitter, have gained interest among the cardiovascular community as a modality for dissemination of cardiovascular research as well as a tool to assess the performance of scholarly articles on Web-based media and social media.
Journal ArticleDOI
Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.
Dhruv Mahtta,David Ramsey,Michelle T. Lee,Xiang Chen,Mahmoud Al Rifai,Julia M. Akeroyd,Elizabeth M Vaughan,Michael E. Matheny,Karla Rodriguesdo Espirito Santo,Sankar D. Navaneethan,Carl J. Lavie,Yochai Birnbaum,Christie M. Ballantyne,Laura A. Petersen,Salim S. Virani +14 more
TL;DR: Overall utilization rates of SGLT2i and GLP-1 RA among eligible patients are low, with significantly higher residual facility-level variation in the use of these drug classes, which suggest opportunities to optimize their use to prevent future adverse cardiovascular events among these patients.
Journal ArticleDOI
From CoreValve to Evolut PRO: Reviewing the Journey of Self-Expanding Transcatheter Aortic Valves
TL;DR: In this review, the evidence behind the use of TAVR, improvement in devices over previous generations, clinical evidencebehind the CoreValve Evolut PRO system, and the future of T AVR are highlighted.